Peak postoperative C-reactive protein levels and long-term mortality in a mixed surgical ICU population: A retrospective, observational-analytical study

Chirurgia

Volumn 24, Issue 3, 2011, Pages 125-131

  Grander, W ^a   Luckner, G ^b   Torgersen, C ^c   Schmittinger, C A ^c   Rex, C ^d   Dunser M W ^c  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^c UNIVERSITY OF BERN   (Switzerland)

^d Kreiskliniken Reutlingen ^*  (Germany)

Author keywords

C reactive protein; Intensive care units; Surgical procedures, operative

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGED; ARTICLE; CARDIOVASCULAR SURGERY; CRITICALLY ILL PATIENT; FEMALE; HUMAN; IMMUNITY; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; POSTOPERATIVE PERIOD; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; SURGICAL PATIENT;

EID: 80052317065     PISSN: 03949508     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Haffner SM. The metabolic syndrome: inflammation, diabetes mellitus, and cardiovascular disease. Am J Cardiol 2006;97:3-11.
2. Panichi V, Taccola D, Rizza GM, Consani C, Ghiadoi L, Filippi C et al. Interleukin-8 is a powerful prognostic predictor of all-cause and cardiovascular mortality in dialytic patients. Nephron Clin Pract 2006;102:51-8.
3. Ridker PM. Inflammatory biomarkers and risks of myocardial infarction, stroke, diabetes, and total mortality: implications for longevity. Nutr Rev 2007;65:S253-9.
4. Pai JK, Pischon T, Ma J, Manson JE, Hankinson SE, Joshipura K et al. Inflammatory markers and the risk of coronary heart disease in men and women. N Engl J Med 2004;351:2599-610. (Pubitemid 39628581)
5. Grander W, Dünser MW, Stollenwerk B, Siebert U, Dengg C, Koller B et al. CRP levels and post-intensive care unit mortality in non-surgical intensive care patients. Chest 2010; epub ahead of print.
6. Ridker PM, Danielson E, Fonseca FA, Genesi J, Gotto AM Jr, Kastelein JJ et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 2008;359:2195-207.
7. Kohl BA, Deutschmann CS. The inflammatory response to surgery and trauma. Curr Opin Crit Care 2006;12:235-42.
8. Aouifi A, Piriou V, Blanc P, Bouvier H, Bastien O, Chiari P et al. Effect of cardiopulmonary bypass on serum procalcitonin and Creactive protein concentrations. Br J Anaesth 1999;83:602-7. (Pubitemid 29458826)
9. Pinilla JC, Hayes P, Lavertry W, Bouxsein ML, Myers ER, Hayes WC. The C-reactive protein to prealbumin ratio correlates with the severity of multiple organ dysfunction. Surgery 1998;124:799-805.
10. Lobo SM, Lobo FR, Bota DP, Lopes-Ferreira F, Soliman HM, Melot C et al. C-reactive protein levels correlate with mortality and organ failure in critically ill patients. Chest 2003;123:2043-9.
11. Keats AS. The ASA classification of physical status - a recapitulation. Anesthesiology 1978;49:233-6.
12. Le Gall JR, Lemeshow S, Saulnier F. A new Simplified Acute Physiologic Score (SAPS II) based on a European/North American multicenter study. JAMA 1993;270:2957-63. (Pubitemid 24000804)
13. Sturk A, Hack CE, Aarden LA, Brouwer M, Koster RR, Sanders GT Interleukin-6 release and the acute-phase reaction in patients with acute myocardial infarction: a pilot study. J Lab Clin Med 1992;119:574-9.
14. Adler G, Eichman W, Szcepanski M, Targonska I, Jasinska A. Postoperative plasma interleukin-6 in patients with renal cancer correlates with C-reactive protein but not with total fibrinogen or with high molecular weight fibrinogen fraction. Thromb Res 1998;89:243-8. (Pubitemid 28298947)
15. Póvoa P. C-reactive protein: a valuable marker of sepsis. Intensive Care Med 2002;28:235-43. (Pubitemid 34230643)
16. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000;342:836-43. (Pubitemid 30165206)
17. Musunuru K, Kral BG, Blumenthal RS, Fuster V, Campbell CY, Gluckman TJ et al. The use of high-sensitivity assays for C-reactive protein in clinical practice. Nat Clin Pract Cardiovasc Med 2008;5:621-35.
18. Willimas TA, Dobb GJ, Finn JC, Knuiman MW, Geelhoed E, Lee KY et al. Determinants of long-term survival after intensive care. Crit Care Med 2008;36:1523-30. (Pubitemid 351620661)
19. Mayr VD, Dünser MW, Greil V, Jochberger S, Luckner G, Ulmer H et al. Causes of death and determinants of outcome in critically ill patients. Crit Care 2006;10:R154.
20. Marshall JC. Inflammation, coagulopathy, and the pathogenesis of multiple organ dysfunction syndrome. Crit Care Med 2001;29(Suppl 7):99-106.
21. Libby P, Ridker PM, Hansson GK; Leducq Transatlantic Network on Atherothrombosis. Inflammation in atherosclerosis: from pathophysiology to practice. J Am Coll Cardiol 2009;54:2129-38.
22. Landray MJ, Wheeler DC, Lip GY, Newman DJ, Blann AD, McGlynn FJ et al. Inflammation, endothelial dysfunction, and platelet activation in patients with chronic kidney disease: the chronic renal impairment in Birmingham (CRIB) study. Am J Kidney Dis 2004;43:244-53. (Pubitemid 38146322)
23. Shepherd J. Who should receive a statin these days? Lessons from recent clinical trials. J Intern Med 2006;260:305-19. (Pubitemid 44370904)
24. Kertai MD, Boersma E, Westerhout CM, van Domburg R, Klein J, Bax JJ et al. Association between long-term statin use and mortatliy after successful abdominal aortic aneurysm surgery. Am J Med 2004;116:96-103. (Pubitemid 38056662)
25. Kulik A, Ruel M. Statins and coronary artery bypass graft surgery: preoperative and postoperative efficacy and safety. Expert Opin Drug Saf 2009;8:559-71.
26. Schouten O, Boersma E, Hoeks SE, Brenner R, van Urk H, van Sambeek MRHM et al. Fluvastatin and perioperative events in patients undergoing vascular surgery. N Engl J Med 2009;361:980-9.